Last week our CEO Greg Smith took part in a panel moderated by Bloomberg's Ashleigh Furlong alongside several other industry peers and experts (Richard Bungay, Linden Thomson, CFA, Clare Terlouw and Bernard Cooney) at the London Stock Exchange’s Future of Healthcare Investment Forum entitled ‘Financing Healthcare – UK, US, Private and Public’. This marked a great opportunity to discuss the recent challenges and future opportunities in the healthcare sector, particularly long-term capital interest in science and technology scale up investment. IP Group plc is the UK’s most active investor in science and innovation companies and are behind some of most exciting breakthroughs of the last 20 years. We are strategically positioned to capitalise on the rapid advancements in pharmaceuticals and healthcare delivery, with over ten companies now in clinical studies and expecting key data by the end of 2025. We believe the UK can be a science superpower - if we get the conditions right. #LifeSciences #Healthcare
IP Group plc’s Post
More Relevant Posts
-
"Value creation is a term that is frequently used but often misunderstood. In healthcare, we believe true value creation goes beyond financial success and also creates a positive impact on the patients, medical community and overall society. At CBC Group, we seek to widen access to affordable medical healthcare, catalyze innovations globally, and fulfill unmet medical needs," said Billy Cho, Senior Managing Director, Private Equity and Head of Joint Value Creation of CBC Group, during a panel discussion at the 2024 Private Equity Asia Forum organized by Markets Group. Titled "Portfolio Optimization & Value Creation – Tools & Strategies Leading Funds use to Support Growth & Reduce Costs", Billy and his fellow panelists discussed strategies to increase productivity while launching new products and entering new markets, highlighting the various tactics GPs are utilizing to preserve liquidity, drive earnings growth, and most importantly – create long term value! #CBCGroup #PrivateEquity #ValueCreation #InvestorOperator #Healthcare #Investments #MarketsGroupPE
-
-
The #healthcare sector continued to be a hub of private equity deal activity in 2023, relative to all PE deals across the world, despite higher global interest rates, inflationary pressures, and broader geopolitical uncertainty. Learn more in Bain & Company’s 2024 Global Healthcare Private Equity Report.
-
Senior Partner | Digital, Agribusiness, Industrials, Retail, Healthcare & Life Sciences and Performance Improvement
The #healthcare sector continued to be a hub of private equity deal activity in 2023, relative to all PE deals across the world, despite higher global interest rates, inflationary pressures, and broader geopolitical uncertainty. Learn more in Bain & Company’s 2024 Global Healthcare Private Equity Report.
Healthcare Private Equity Market 2023: Year in Review and Outlook
bain.com
-
The #healthcare sector continued to be a hub of private equity deal activity in 2023, relative to all PE deals across the world, despite higher global interest rates, inflationary pressures, and broader geopolitical uncertainty. Learn more in Bain & Company’s 2024 Global Healthcare Private Equity Report.
Healthcare Private Equity Market 2023: Year in Review and Outlook
bain.com
-
Challenges and opportunities in healthcare investing. In this article titled 'HQH: Remains Beaten Down But Also Remains An Interesting Prospect,' Nick Ackerman of Seeking Alpha delves into the challenges and opportunities of abrdn Healthcare Investors (HQH). Despite the ongoing pressures in the healthcare and biotech sectors, Ackerman highlights HQH's attractive buy potential, especially for those betting on a sector rebound, and its significant discount in the current market. This piece offers a comprehensive analysis of HQH's performance, investment strategy, and the potential for long-term capital appreciation, making it a must-read for investors interested in the healthcare investment space. https://lnkd.in/gtsfRMqT #HealthcareInvesting #BiotechSector #InvestmentAnalysis #HQH #MarketInsights
-
Vice President at Mastercard Advisors - EEMEA Head of Client Funded Services (18 countries) | Forward-thinking strategic leader | Value-focus | Disruptive mindset | Tech-Data expertise | ex Bain & Accenture Partner
The #healthcare sector continued to be a hub of private equity deal activity in 2023, relative to all PE deals across the world, despite higher global interest rates, inflationary pressures, and broader geopolitical uncertainty. Learn more in Bain & Company’s 2024 Global Healthcare Private Equity Report.
Healthcare Private Equity Market 2023: Year in Review and Outlook
bain.com
-
The #healthcare sector continued to be a hub of private equity deal activity in 2023, relative to all PE deals across the world, despite higher global interest rates, inflationary pressures, and broader geopolitical uncertainty. Learn more in Bain & Company’s 2024 Global Healthcare Private Equity Report.
Healthcare Private Equity Market 2023: Year in Review and Outlook
bain.com
-
The #healthcare sector continued to be a hub of private equity deal activity in 2023, relative to all PE deals across the world, despite higher global interest rates, inflationary pressures, and broader geopolitical uncertainty. Learn more in Bain & Company’s 2024 Global Healthcare Private Equity Report.
Healthcare Private Equity Market 2023: Year in Review and Outlook
bain.com
-
The #healthcare sector continued to be a hub of private equity deal activity in 2023, relative to all PE deals across the world, despite higher global interest rates, inflationary pressures, and broader geopolitical uncertainty. Learn more in Bain & Company’s 2024 Global Healthcare Private Equity Report.
Healthcare Private Equity Market 2023: Year in Review and Outlook
bain.com
